Private company

MedAvail Holdings, Inc.

American Retail-Drug Stores and Proprietary Stores company based in Phoenix1

In its 2023 annual report the company says: “We are a pharmacy technology and services company that develops and commercializes an innovative self-service pharmacy, mobile application, and kiosk.”78

Last updated Oct 20, 2026.

Overview

  • IndustryRetail-Drug Stores and Proprietary Stores1
  • HeadquartersPhoenix, Arizona1
  • Incorporated inDE2
  • Business address4720 E Cotton Gin Loop, Suite 220, Phoenix, Az 850402
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

6.0%Gross margin3
-107.7%Operating margin3
-110.5%Net margin3
94.8%Revenue growth, 20223
-228.7%Return on equity3
0.23×Debt to equity3
-$48.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue94¢$40.5M
  • Research and development3¢$1.1M
  • Other costs1¢$274.0K
  • Interest3¢$1.2M
  • Income tax0¢$24.0K

Out of $43.1M in revenue.3 The company lost money this year.

Financial statements

Revenue456783$43.1M in 2022+13083% since 2016
0$20.0M$40.0M$60.0M2016: $327.0K$327.0K20162017: $526.0K$526.0K2017+61%2018: $360.0K$360.0K2018−32%2019: $3.8M$3.8M2019+948%2020: $14.0M$14.0M2020+270%2021: $22.1M$22.1M2021+58%2022: $43.1M$43.1M2022+95%
Gross profit456783$2.6M in 2022+32212% since 2016
0$2.0M$4.0M$6.0M2016: $8.0K$8.0K20162017: $218.0K$218.0K2017+2625%2018: $112.0K$112.0K2018−49%2019: $948.0K$948.0K2019+746%2020: $5.2M$5.2M2020+445%2021: $317.0K$317.0K2021−94%2022: $2.6M$2.6M2022+715%
Operating income456783-$46.4M in 2022+978% since 2016
-$60.0M-$40.0M-$20.0M02016: -$4.3M-$4.3M20162017: -$4.1M-$4.1M2017−6%2018: -$4.3M-$4.3M2018+6%2019: -$20.8M-$20.8M2019+381%2020: -$25.5M-$25.5M2020+22%2021: -$43.5M-$43.5M2021+71%2022: -$46.4M-$46.4M2022+7%
Net income456783-$47.6M in 2022+997% since 2016
-$60.0M-$40.0M-$20.0M02016: -$4.3M-$4.3M20162017: -$4.1M-$4.1M2017−7%2018: -$3.2M-$3.2M2018−21%2019: -$21.5M-$21.5M2019+568%2020: -$26.8M-$26.8M2020+25%2021: -$43.8M-$43.8M2021+63%2022: -$47.6M-$47.6M2022+9%
Fiscal year2016201720182019202020212022
Revenue$327.0K4$526.0K5$360.0K6$3.8M7$14.0M8$22.1M3$43.1M3
Cost of revenue$319.0K4$308.0K5$248.0K6$2.8M7$8.8M8$21.8M3$40.5M3
Gross profit$8.0K4$218.0K5$112.0K6$948.0K7$5.2M8$317.0K3$2.6M3
Research and development$011$240.0K5$145.0K6$1.1M7$682.0K8$849.0K3$1.1M3
Selling, general and admin
Operating expenses$43.8M3$49.0M3
Operating income-$4.3M4-$4.1M5-$4.3M6-$20.8M7-$25.5M8-$43.5M3-$46.4M3
Interest$35.0K4$2.0K5$16.0K6$734.0K7$1.2M8$589.0K3$1.2M3
Income before tax-$43.8M3-$47.6M3
Income tax-$1.1M6$07$08$2.0K3$24.0K3
Net income-$4.3M4-$4.1M5-$3.2M6-$21.5M7-$26.8M8-$43.8M3-$47.6M3
Earnings per share-$13.377-$4.698-$1.343-$0.723
Earnings per share (diluted)-$13.377-$4.698-$1.343-$0.723
Shares (weighted, basic)32.7M shares365.8M shares3
Shares (weighted, diluted)32.7M shares365.8M shares3

Compare MedAvail Holdings, Inc. with another company

Corporate structure

MedAvail Holdings, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of MedAvail Holdings, Inc.

  • Alyeska Investment Group, L.P. Filed SC 13G/A on MedAvail Holdings, Inc., latest Feb 14, 2024 (2 filings since Feb 14, 2023)
  • Redmile Group, LLC Filed SC 13D/A on MedAvail Holdings, Inc., latest Feb 6, 2024 (7 filings since Nov 29, 2021)
  • Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Filed SC 13D/A on MedAvail Holdings, Inc., latest Jun 21, 2023 (3 filings since Apr 6, 2022)
  • PURA VIDA INVESTMENTS, LLC Filed SC 13G/A on MedAvail Holdings, Inc., latest Feb 14, 2022
  • ADAGE CAPITAL PARTNERS GP, L.L.C. Filed SC 13G/A on MedAvail Holdings, Inc., latest Feb 10, 2022
  • MedAvail Holdings, Inc. Phoenix, Arizona

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What MedAvail Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$13.0M3 Dec 31, 2022$11.2M3 Dec 31, 2021+16.2%
Accumulated depreciation$6.5M3 Dec 31, 2022$5.5M3 Dec 31, 2021+19.0%
Property and equipment, net$6.5M3 Dec 31, 2022$5.7M3 Dec 31, 2021+13.4%
Finance-lease assets$132.0K3 Dec 31, 2022$162.0K3 Dec 31, 2021−18.5%
Operating-lease assets (leased space)$2.0M3 Dec 31, 2022$2.4M3 Dec 31, 2021−17.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$11.4M3 Dec 31, 2022$19.7M3 Dec 31, 2021−41.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$9.8M3 Dec 31, 2022$8.9M3 Dec 31, 2021+9.5%
Accumulated amortization$9.3M3 Dec 31, 2022$6.6M3 Dec 31, 2021+40.5%
Finite-lived intangibles, net$465.0K3 Dec 31, 2022$2.3M3 Dec 31, 2021−79.8%

Inventory

ItemLatestA year beforeChange
Inventory, total$6.9M3 Dec 31, 2022$3.9M3 Dec 31, 2021+77.1%
Raw materials$1.2M8 Dec 31, 2021$1.7M8 Dec 31, 2020−27.4%
Finished goods$3.3M3 Dec 31, 2022$1.2M3 Dec 31, 2021+177.4%

Leadership

Who has led MedAvail Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Glen R. Fleischer2013
  2. Kenrick Bryce Toussaint2015
  3. Joseph Mannello2016–2020
  4. Edwin Kilroy2020–2022
  5. Mark Edward Doerr2022–2023

President

  1. Joseph Dossantos2015

Chief financial officer

  1. Andrew J. Einhorn2012
  2. Carl Defreitas2013–2014
  3. Joseph Dossantos2014–2015
  4. Ryan Ferguson2020–2021
  5. Ramona Seabaugh2021–2023
201520202025
Board members and other officers (33)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorPaul D. Johnson named Apr 19, 202254

Former names

  • MYOS RENS TECHNOLOGY INC.Mar 22, 2016 to Nov 18, 20202
  • MYOS CorpMay 21, 2012 to Mar 14, 20162
  • Atlas Therapeutics CorpAug 12, 2010 to May 15, 20122
  • Rough Tide Marine Operations, Inc.Jun 9, 2010 to Jun 9, 20102
  • Marvin's Place, Inc.Jun 27, 2007 to May 28, 20102

Timeline

  1. Feb 8, 20248-K Listing notice or transfer55
  2. Feb 2, 20248-K Bankruptcy or receivership; Change of auditor; Executive or director change56
  3. Jan 23, 20248-K Exit or restructuring costs57
  4. Nov 17, 20238-K Listing notice or transfer58
  5. Nov 14, 20238-K Other events59
  6. Aug 18, 20238-K Code of ethics changed60
  7. Aug 14, 20238-K Results of operations; Regulation FD disclosure61
  8. Jul 31, 20238-K Change to shareholders' rights; Bylaws or fiscal year changed; Regulation FD disclosure62
  9. Jun 29, 20238-K Other events63
  10. Jun 16, 20238-K Change of auditor; Shareholder vote; Other events64
  11. May 18, 20238-K Results of operations65
  12. May 8, 20238-K Change of auditor66
  13. Jan 12, 2022New chief executive Mark Edward Doerr becomes CEO12
  14. Nov 18, 2020New chief executive Edwin Kilroy becomes CEO13
  15. Dec 30, 2016New chief executive Joseph Mannello becomes CEO14
  16. Dec 29, 2015New chief executive Kenrick Bryce Toussaint becomes CEO15
  17. Jan 8, 2013New chief executive Glen R. Fleischer becomes CEO16

Calendar

When it reported results

  1. Aug 14, 2023Reported quarterly or annual results61
  2. May 18, 2023Reported quarterly or annual results65
  3. Apr 13, 2023Reported quarterly or annual results67
  4. Jan 26, 2023Reported quarterly or annual results68
  5. Jan 19, 2023Reported quarterly or annual results69
  6. Nov 10, 2022Reported quarterly or annual results70
  7. Aug 11, 2022Reported quarterly or annual results71
  8. May 12, 2022Reported quarterly or annual results72

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

137 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 40 major events, 40 insider forms, 14 large holders, 1 private raises, 34 other. The latest 20:

  1. Feb 14, 2024SC 13G/A EDGAR
  2. Feb 8, 20248-K EDGAR
  3. Feb 6, 20244 OWNERSHIP DOCUMENT EDGAR
  4. Feb 6, 2024SC 13D/A EDGAR
  5. Feb 2, 20248-K EDGAR
  6. Jan 23, 20248-K EDGAR
  7. Nov 17, 20238-K EDGAR
  8. Nov 15, 2023NT 10-Q EDGAR
  9. Nov 14, 20238-K EDGAR
  10. Oct 2, 20234 PRIMARY DOCUMENT EDGAR
  11. Aug 21, 20234 PRIMARY DOCUMENT EDGAR
  12. Aug 21, 20234 PRIMARY DOCUMENT EDGAR
  13. Aug 18, 20238-K EDGAR
  14. Aug 14, 202310-Q EDGAR
  15. Aug 14, 20238-K EDGAR
  16. Jul 31, 20238-K EDGAR
  17. Jul 19, 2023EFFECT EDGAR
  18. Jul 18, 2023CORRESP EDGAR
  19. Jul 14, 2023S-3/A EDGAR
  20. Jul 10, 2023UPLOAD EDGAR

The 137 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 1 buys and 5 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 28, 2023Seabaugh RamonaChief Financial OfficerSale303$5.70$1.7KForm 4
Mar 21, 2023Seabaugh RamonaChief Financial OfficerSale3,287$0.31$1.0KForm 4
Mar 6, 2023Doerr Mark EdwardChief Executive OfficerSale72,785$0.31$22.6KForm 4
Mar 3, 2023Seabaugh RamonaChief Financial OfficerSale6,727$0.34$2.3KForm 4
Mar 3, 2023Doerr Mark EdwardChief Executive OfficerSale20,773$0.33$6.9KForm 4
Apr 4, 2022ABG-WTT Global Life Science Capital Partners GP, L.P.10% ownerBuy14,117,646$1.06$15.0MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Apr 4, 2022Raised $40 million in a private offering of equity Form D: $79.4 million offered in all Form D

SEC filer profile

How MedAvail Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMedAvail Holdings, Inc.1
  • CIK0001402479
  • Employer ID (EIN)90-07723941
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)5912 Retail-Drug Stores and Proprietary Stores1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address4720 E Cotton Gin Loop, Suite 220, Phoenix, AZ 850401
  • Phone1.877.830.08261
  • Shares outstanding1,613,911 as of Aug 8, 202310
  • Public float$63.6M as of Jun 30, 20223
  • On EDGAR sinceJun 27, 20071
  • Filings629 in all: 4 (163), 8-K (146), 3 (51), 10-Q (46), CORRESP (18), UPLOAD (16), 10-K (15), EFFECT (15)1
    All 46 form types

    DEF 14A (12), SC 13D/A (11), 424B3 (10), SC 13G (10), 425 (9), S-3 (9), SC 13D (9), NT 10-Q (8), SC 13G/A (8), D (6), PRE 14A (6), S-1/A (6), 424B5 (5), S-3/A (5), DEFA14A (4), NT 10-K (4), S-8 (4), 10-Q/A (3), CT ORDER (3), S-1 (3), 10-K/A (2), 10QSB (2), 8-A12B (2), 8-K/A (2), DEF 14C (2), PRE 14C (2), 10KSB (1), 144 (1), 25-NSE (1), 5 (1), 8-A12G (1), CERTNAS (1), POS AM (1), RW (1), S-4 (1), S-4/A (1), SB-2 (1), SC 14F1 (1)

  • Latest filingsAnnual report (10-K) Apr 14, 2023
    Quarterly report (10-Q) Aug 14, 2023
    Proxy statement (DEF 14A) May 1, 2023
    Latest 8-K (8-K) Feb 8, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
    SEC EDGAROther events
  60. 60
  61. 61
  62. 62
  63. 63
    SEC EDGAROther events
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78